CMPI
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
CMPI
Delisted
CMPI was delisted on the 27th of May, 2022.
37 hedge funds and large institutions have $202M invested in Checkmate Pharmaceuticals, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
37
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$3M | |
| 2 | +$1.48M | |
| 3 | +$868K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$808K |
| 5 |
CT
Cambridge Trust
Cambridge,
Massachusetts
|
+$299K |
Top Sellers
| 1 | -$886K | |
| 2 | -$796K | |
| 3 | -$85.4K | |
| 4 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$60.5K |
| 5 |
Morgan Stanley
New York
|
-$42.4K |